The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Effect of baseline QTc interval prolongation on oncology clinical trial enrollment.
Carolina Moreno
No relevant relationships to disclose
Jill M. Weber
No relevant relationships to disclose
Maya Guglin
No relevant relationships to disclose
Larry Roy
No relevant relationships to disclose
Jonathan R. Strosberg
No relevant relationships to disclose